Agios Pharmaceuticals, Inc. SEC filings AGIO
Agios Pharmaceuticals, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Dec 7, 2015. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 18, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 12, 2026 | — |
| S-8 | Employee stock plan registration | Jun 18, 2025 | — |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| S-8 | Employee stock plan registration | Jun 13, 2023 | — |
| S-8 | Employee stock plan registration | Feb 23, 2023 | — |
| S-3ASR | Automatic shelf registration | Feb 23, 2023 | — |
| S-8 | Employee stock plan registration | Jan 3, 2023 | — |
| S-8 | Employee stock plan registration | Sep 26, 2022 | — |
| S-8 | Employee stock plan registration | Aug 8, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| S-3ASR | Automatic shelf registration | Apr 30, 2020 | — |
| S-8 | Employee stock plan registration | Feb 19, 2020 | — |
| 424B5 | Prospectus supplement | Nov 8, 2019 | — |
| 424B5 | Prospectus supplement | Nov 6, 2019 | — |
| S-8 | Employee stock plan registration | Feb 14, 2019 | — |
| S-8 | Employee stock plan registration | Feb 14, 2018 | — |
| 424B5 | Prospectus supplement | Jan 19, 2018 | — |
| 424B5 | Prospectus supplement | Jan 17, 2018 | — |
| S-3ASR | Automatic shelf registration | Dec 8, 2017 | — |
| 424B5 | Prospectus supplement | Apr 19, 2017 | — |
| 424B5 | Prospectus supplement | Apr 17, 2017 | — |
| S-8 | Employee stock plan registration | Feb 16, 2017 | — |
| 424B5 | Prospectus supplement | Sep 15, 2016 | — |
| 424B5 | Prospectus supplement | Sep 13, 2016 | — |
| S-8 | Employee stock plan registration | Feb 26, 2016 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AGIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1439222
- Former names
- AGIOS PHARMACEUTICALS INC (until Jul 16, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.